Publications by authors named "Jennifer R Cromer"

The Mini-Mental State Exam (MMSE) is a clinically ubiquitous yet incompletely standardized instrument. Though the test offers considerable examiner leeway, little data exist on the normative consequences of common administration variations. We sought to: (a) determine the effects of education, age, gender, health status, and a common administration variation (serial 7s subtraction vs.

View Article and Find Full Text PDF

Background: Early invasive electrical stimulation studies suggested that enhancement of cerebellar vermal activity might prove valuable in symptomatic treatment of refractory neuropsychiatric diseases via modulation of emotion and affect. This proof of principle study aimed to test this hypothesis using noninvasive brain stimulation, and to explore the safety of this protocol in schizophrenia.

Methods: Eight treatment-refractory patients with schizophrenia underwent ten sessions of intermittent theta burst stimulation (TBS) to the cerebellar vermis using MRI-guided transcranial magnetic stimulation (TMS).

View Article and Find Full Text PDF

Several psychological constructs (e.g., subjective perception of intoxication, visuomotor speed) display acute tolerance to alcohol, that is, show improvement at declining blood alcohol concentrations (BACs) relative to equivalent rising BACs.

View Article and Find Full Text PDF

This study used a novel hidden maze learning test to examine the nature and magnitude of impairment on separable aspects of executive function in 36 children with ADHD. A within-subject analysis of children with ADHD was also conducted to assess cognitive effects of open-label stimulant treatment. Compared to 31 age-matched controls, unmedicated children with ADHD were slower and made significantly more errors that were indicative of relative impairment in prepotent response inhibition and ability to "maintain set" while using simple rules to complete the task.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how effective donepezil, a treatment for Alzheimer's, is at boosting cognitive performance in healthy older adults using a scopolamine-induced dementia model.
  • Thirty-two participants were split into groups under a double-blind, placebo-controlled setup, taking either donepezil or a placebo, with tests on visuospatial working memory through the Groton Maze Learning Test done at various points post-dosing.
  • Results showed that donepezil significantly improved cognitive functions, reversing the impairments caused by scopolamine and enhancing abilities like psychomotor speed and learning efficiency when taken alone.
View Article and Find Full Text PDF